Kobo Biotech Ltd
Kobo Biotech is engaged in the business of Pharmaceutical products.
- Market Cap ₹ 9.05 Cr.
- Current Price ₹ 3.80
- High / Low ₹ 6.01 / 1.86
- Stock P/E
- Book Value ₹ -54.7
- Dividend Yield 0.00 %
- ROCE -36.8 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
167.03 | 170.15 | 56.89 | 29.05 | 32.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
125.51 | 134.40 | 61.34 | 38.51 | 27.74 | 4.05 | 3.02 | 1.72 | 0.69 | 2.79 | 10.51 | 1.50 | 1.42 | |
Operating Profit | 41.52 | 35.75 | -4.45 | -9.46 | 4.80 | -4.05 | -3.02 | -1.72 | -0.69 | -2.79 | -10.51 | -1.50 | -1.42 |
OPM % | 24.86% | 21.01% | -7.82% | -32.56% | 14.75% | ||||||||
0.23 | 0.22 | 0.18 | 2.60 | 0.42 | 6.00 | 0.04 | -2.15 | 0.03 | 0.04 | 0.02 | 0.02 | 0.02 | |
Interest | 19.54 | 17.21 | 18.14 | 15.62 | 14.37 | 14.41 | 14.50 | 14.44 | 14.47 | 10.84 | 0.13 | 0.00 | 0.00 |
Depreciation | 10.86 | 9.97 | 9.62 | 7.78 | 7.31 | 6.78 | 6.44 | 6.15 | 5.88 | 5.64 | 4.61 | 4.07 | 4.06 |
Profit before tax | 11.35 | 8.79 | -32.03 | -30.26 | -16.46 | -19.24 | -23.92 | -24.46 | -21.01 | -19.23 | -15.23 | -5.55 | -5.46 |
Tax % | 11.37% | 5.92% | -1.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
10.07 | 8.27 | -32.57 | -30.26 | -16.46 | -19.24 | -23.92 | -24.46 | -21.01 | -19.23 | -15.23 | -5.55 | -5.47 | |
EPS in Rs | 4.48 | 3.68 | -14.48 | -13.45 | -6.94 | -8.08 | -10.04 | -10.27 | -8.82 | -8.07 | -6.39 | -2.33 | -2.30 |
Dividend Payout % | 22.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | 20% |
TTM: | 61% |
Stock Price CAGR | |
---|---|
10 Years: | -9% |
5 Years: | -4% |
3 Years: | -20% |
1 Year: | 95% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 22.50 | 22.50 | 22.50 | 22.50 | 23.73 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 |
Reserves | 46.37 | 54.64 | 22.07 | -8.83 | -17.30 | -42.41 | -66.33 | -90.79 | -111.80 | -131.03 | -146.25 | -151.81 | -154.25 |
117.99 | 131.49 | 136.99 | 142.42 | 152.68 | 207.60 | 221.96 | 236.36 | 250.76 | 260.53 | 140.71 | 139.84 | 139.69 | |
70.63 | 69.01 | 97.45 | 95.74 | 101.36 | 63.20 | 66.48 | 70.04 | 73.54 | 77.26 | 60.89 | 63.47 | 64.07 | |
Total Liabilities | 257.49 | 277.64 | 279.01 | 251.83 | 260.47 | 252.22 | 245.94 | 239.44 | 236.33 | 230.59 | 79.18 | 75.33 | 73.34 |
100.17 | 107.77 | 103.52 | 95.10 | 87.79 | 81.01 | 74.56 | 68.42 | 62.54 | 56.91 | 41.66 | 37.59 | 35.56 | |
CWIP | 13.49 | 2.92 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 0.00 | 0.00 | 0.00 |
Investments | 10.76 | 12.19 | 12.19 | 12.19 | 12.19 | 12.19 | 12.19 | 12.19 | 12.19 | 12.19 | 0.00 | 0.00 | 0.00 |
133.07 | 154.76 | 161.05 | 142.29 | 158.24 | 156.77 | 156.94 | 156.58 | 159.35 | 159.24 | 37.52 | 37.74 | 37.78 | |
Total Assets | 257.49 | 277.64 | 279.01 | 251.83 | 260.47 | 252.22 | 245.94 | 239.44 | 236.33 | 230.59 | 79.18 | 75.33 | 73.34 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
57.55 | 38.42 | 11.02 | 19.32 | 5.62 | 32.30 | 31.47 | 20.95 | 14.48 | 2.51 | 93.76 | 0.87 | |
-25.19 | -8.42 | -4.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 25.09 | 0.00 | |
-26.98 | -35.76 | -7.00 | -20.50 | -5.27 | -32.76 | -31.47 | -20.95 | -14.47 | -1.08 | -120.28 | -0.87 | |
Net Cash Flow | 5.38 | -5.76 | -0.69 | -1.18 | 0.35 | -0.46 | 0.00 | 0.00 | 0.00 | 1.43 | -1.43 | 0.00 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 143.15 | 156.49 | 419.02 | 705.62 | 1,006.50 | |||||||
Inventory Days | 176.24 | 207.82 | 585.06 | 896.42 | 1,038.63 | |||||||
Days Payable | 134.95 | 96.88 | 404.72 | 659.54 | 1,092.57 | |||||||
Cash Conversion Cycle | 184.44 | 267.42 | 599.37 | 942.51 | 952.56 | |||||||
Working Capital Days | 151.37 | 197.93 | 571.21 | 829.89 | 821.19 | |||||||
ROCE % | 15.48% | 13.15% | -7.12% | -10.18% | -1.33% | -2.77% | -5.11% | -4.49% | -3.94% | -5.31% | -17.60% | -36.82% |
Documents
Announcements
- Closure of Trading Window 1d
- Financial Result For The Quarter And Nine Months Ended 31St December, 2023 14 Feb
- Board Meeting Intimation for Approval Of The Unaudited Financial Statements For The Quarter And Nine Months Ended 31St December 2023. 7 Feb
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
23 Jan - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018
- Closure of Trading Window 28 Dec 2023
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse